ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1815

STAT3-Mediated Regulation of Mitochondrial Membrane Potential Is Critical for NLRP3 Inflammasome Activation

Jehad H. Edwan1, Raphaela Goldbach-Mansky2 and Robert A. Colbert3, 1NIAMS NIH, Bethesda, MD, 2NIAMS, NIH Building 10 Room 6D47B, Bethesda, MD, 3NIAMS/NIH, Bethesda, MD

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: IL-1/IL-18, inflammasome activation, Inflammation, innate immunity and monocytes

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Self-activating mutations in NLRP3 cause a spectrum of autoinflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS). NLRP3 is a key component of a multiprotein complex known as the inflammasome that mediates the maturation of the proinflammatory cytokine IL-1beta, and can induce rapid cell death in a process known as pyronecrosis. Although several models for inflammasome activation have been proposed the precise molecular mechanism, as well as the role of NRLP3 mutations, remains to be elucidated. Emerging evidence suggests that mitochondria are involved in inflammasome activation. STAT3 associates with the mitochondrial inner membrane in a GRIM-19 dependent manner and has been implicated in regulating cellular respiration. Here we asked whether regulation of mitochondrial membrane potential plays a role in NLRP3 inflammasome activation.
Methods: We used whole blood cells from NOMID patients and healthy controls, THP-1 cells with STAT3, NLRP3, GRIM-19, or OSCP expression knocked down, and monocytes derived from NLRP3-deficient mice. Cells were stimulated with LPS in the presence of inhibitors of STAT3, followed by ATP. Cell supernatants were collected and incubated with IL-1beta-capturing beads. Cells were fixed and permeabilized. Then beads were added back to cells, and the mixture of cells with beads was stained with anti-IL-1beta, CD14, and CD16 antibodies and then evaluated by flow cytometry. LPS stimulated cells were also evaluated using immunofluorescence and western blot analysis.
Results: By flow analysis we provide evidence that inhibition of STAT3 function in NOMID and healthy control monocytes, as well as knockdown of STAT3 in THP-1 cells, results in a significant decrease in inflammasome activation. Using confocal microscopy to visualize pyronecrosis, we provide evidence that this process is NLRP3 dependent.  Knockdown of GRIM-19 in THP-1 cells also inhibited NLRP3 activation, suggesting a requirement for mitochondrial STAT3. Enhancement of the mitochondrial membrane potential in STAT3 knockdown cells bypassed the effect of STAT3 knockdown, and reconstituted inflammasome activation, whereas knockdown of OSCP significantly reduced inflammasome activation.
Conclusion:
These data suggest a previously unrecognized role for STAT3 in regulating mitochondrial membrane potential, which can regulate NLRP3 inflammasome activation. These results point toward mitochondrial STAT3 as a novel therapeutic target for NOMID and other NLRP3-mediated inflammatory diseases.


Disclosure:

J. H. Edwan,
None;

R. Goldbach-Mansky,
None;

R. A. Colbert,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2014

ACR Meeting Abstracts - https://acrabstracts.org/abstract/stat3-mediated-regulation-of-mitochondrial-membrane-potential-is-critical-for-nlrp3-inflammasome-activation/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology